Plain Language Summaries is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • How to
  • FAQs
  • Publications
  • Advisory Panel
    • Plain Language Advisors
    • Scientific Content Advisors
  • Supporters
  • Blog
  • About us
  • Contact Us

Plain language summary of publication

22nd Jan 2026

Plain language summary: Pimavanserin versus other atypical antipsychotics for falls and fractures in long-term care patients with Parkinson’s disease psychosis

16th Sep 2025

Plain language summary: Global Registry data shows patients with aHUS can safely and effectively change from eculizumab to ravulizumab treatment

21st Feb 2025

Plain language summary of the XALOC-1 program: Real-world study on benralizumab for severe eosinophilic asthma across different biologic treatments and clinical subgroups

17th Jan 2025

Plain language summary: the strengths and challenges of optical coherence tomography angiography (OCTA) in diabetic retinopathy

Copyright © 2026 · Plain Language Summaries · Terms and conditions · Privacy policy · Cookie policy